In metabolic disorders driven by overnutrition such as MASLD, AMPK is down-regulated by an excess of nutrients as well as low-grade inflammation (probably by TNFα), leading to a diminishing liver condition, whereas therapeutic effects are observed when AMPK activity is increased [48,49]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.